Skip to content

Electronic Register on Advanced Heart Failure and Transplantation di Cuore

Electronic Register on Advanced Heart Failure and Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06773611
Enrollment
10000
Registered
2025-01-14
Start date
2023-09-04
Completion date
2028-09-30
Last updated
2025-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Heart Transplantation

Brief summary

The goal of this observational study is to create an electronic registry of patients diagnosed with Advanced Heart Failure or Heart Transplant, starting from 01/01/1985 and to assess the incidence of Advanced Heart Failure and Heart Transplant, and characterize patients affected by the first or undergoing the second procedure, starting from 01/01/1985. The primary outcomes are: * Hospitalization for cardiovascular cause * Death

Detailed description

Heart failure is a pathological condition characterized by high morbidity and mortality, and it leads to a significant worsening of the quality of life for patients. The treatment of heart failure involves various options; the goal is to slow down the progression of the disease, reduce hospitalizations, increase survival, and reduce symptoms in order to improve the quality of life. Treatments range from pharmacological therapy to lifestyle changes, from device implantation to heart transplant surgery. Early diagnosis and treatment often help reduce symptoms, and many patients with heart failure can return to an active life. Patients with heart failure must undergo regular check-ups to assess their general physical condition and the status of the disease. It is therefore essential to evaluate and systematize the different therapies. This study is both retrospective and prospective

Interventions

None listed

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Ability to provide informed consent * Diagnosis of Advanced Heart Failure or Heart Transplant

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Hospitalization for cardiovascular cause5 yearsHospitalization for cardiovascular cause
Death5 yearsDeath

Secondary

MeasureTime frameDescription
Hospitalization for non-cardiovascular cause5 yearsHospitalization for non-cardiovascular cause
Implantation of medical device (including mechanical support)5 yearsImplantation of medical device (including mechanical support)
Need for intravenous diuretic therapy5 yearsNeed for intravenous diuretic therapy
Need for hemodialysis event5 yearsNeed for hemodialysis event

Countries

Italy

Contacts

Primary ContactLuciano Potena, MD
scompenso.trapiantocuore@aosp.bo.it051-2143725

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026